Location History:
- Pennington, NJ (US) (2008 - 2021)
- Monmouth Junction, NJ (US) (2019 - 2023)
- Chelsea, MA (US) (2023)
Company Filing History:
12 out of 19 
3 out of 86 
3 out of 1,455 
Years Active: 2008-2023
Title: Michael Voronkov: Innovator in Opioid and Dermatological Therapeutics
Introduction
Michael Voronkov, based in Pennington, NJ, is a renowned inventor with a significant portfolio of 20 patents. His contributions to the fields of opioid therapeutics and dermatological applications reflect his commitment to innovation and improving patient care.
Latest Patents
Voronkov's latest patents focus on compositions and methods for opioid hexadienoates and their applications. One notable invention discusses opiate-derived compositions and their antagonists developed to treat conditions associated with opioid receptor modulation. His work includes a 3-hexadienoate modification of nalbuphine, enhancing pain management through various administration routes, including intravenous, intranasal, and topical methods.
Additionally, Voronkov has also developed a 3-hexadienoate modification for naloxone. This innovation aims to improve sobering effects via multiple administration methods similar to those mentioned above. His commitment extends to compounds designed to treat and prevent various skin conditions, such as inflammation, acne, and bacterial infections, thus promoting healthy skin appearances.
Career Highlights
Throughout his career, Voronkov has made significant contributions while working with notable companies such as Signum Biosciences, Inc. and Lexicon Pharmaceuticals, Inc. His expertise in developing innovative therapeutic solutions has positioned him as a leader in his field.
Collaborations
Voronkov has collaborated with accomplished professionals in the industry, including Jeffry B. Stock and Maxwell Stock. These partnerships highlight the importance of teamwork and shared vision in advancing medical innovations that can significantly benefit patients.
Conclusion
Michael Voronkov continues to push the boundaries of innovation in the therapeutic landscape. With his extensive patent portfolio and collaborations with key industry figures, he exemplifies dedication to enhancing healthcare through strategic invention and development. His work not only impacts the field of opioid therapy but also offers promising advancements in dermatological treatments.